Announcements
- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
- GeneType to Enter Canadian and New Zealand Markets
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
- Genetic Technologies Expands Operational Capacity in North America
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
- GeneType and Humanise Health host “Know Your Risk” Event
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
- Appendix 4C & Quarterly Business Update – March 2024
More ▼
Key statistics
On Friday, Genetic Technologies Ltd (DU8:FRA) closed at 0.017, 3.03% above its 52-week low of 0.0165, set on Jul 25, 2024.
52-week range
Open | 0.017 |
---|---|
High | 0.017 |
Low | 0.017 |
Bid | 0.017 |
Offer | 0.0475 |
Previous close | 0.0165 |
Average volume | 0.00 |
---|---|
Shares outstanding | 145.42m |
Free float | 131.76m |
P/E (TTM) | -- |
Market cap | 6.40m AUD |
EPS (TTM) | -0.1126 AUD |
Data delayed at least 15 minutes, as of Jul 26 2024 07:02 BST.
More ▼